SCHEMBL19543724

SCHEMBL19543724

Cc1cccc(-c2cc(-c3cc(-c4cc(-c5cccc(C)n5)cc(-c5cccc(C)n5)c4)cc(-c4cc(-c5ccccc5)nc(-c5ccccc5)n4)c3)cc(-c3cccc(C)n3)c2)n1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 11/20 0.50
KMT2A Q03164 11/20 0.50
MAPT P10636 8/20 0.50
ALDH1A1 P00352 7/20 0.50
HPGD P15428 6/20 0.50
NTSR1 P30989 1/20 0.50
RAB9A P51151 2/20 0.48
CCR1 P32246 1/20 0.48
CCR8 P51685 1/20 0.48
KDM4E B2RXH2 5/20 0.47
LMNA P02545 3/20 0.47
GLA P06280 1/20 0.47
CYP2A6 P11509 1/20 0.47
ADORA2A P29274 1/20 0.47
ADORA1 P30542 1/20 0.47
POLB P06746 1/20 0.45
PKM P14618 1/20 0.45
TGFBR1 P36897 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16189386 0.92 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19009474 0.92 L3MBTL1 (0.50) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19009571 0.91 MEN1 (0.47) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL23636152 0.90 CCR1 (0.57) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19009464 0.89 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189305 0.89 MEN1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL19009229 0.88 CCR1 (0.58) MEN1KMT2AMAPTALDH1A1RAB9A
SCHEMBL16189381 0.87 MEN1 (0.45) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189550 0.87 CYP1A1 (0.49) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL16189355 0.86 CCR1 (0.52) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11329230-B2 Organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2022-05-10 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed
US-20170317294-A1 ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2017-11-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11329230-B2 Organic light-emitting device EML4, SUN2, TRPA1 MEN1 2816/4885KMT2A 1971/4885MAPT 735/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.